Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero
Authors:
- Eve J. LowensteinELEve J. Lowenstein
- 31 December 2011
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 29 (6) , 652-661
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Case–Control StudyAmerican Journal of Gastroenterology, 2010
- A Causal Association Between Isotretinoin and Inflammatory Bowel Disease Has Yet to Be EstablishedAmerican Journal of Gastroenterology, 2009
- Isotretinoin-associated normalization of hyperbilirubinemia in patients with Gilbert's syndromeJournal of the American Academy of Dermatology, 1995
- Acute depression from isotretinoinJournal of the American Academy of Dermatology, 1990
- Liver toxicity of retinoid therapyJournal of the American Academy of Dermatology, 1988
- Lipid and teratogenic effects of retinoidsJournal of the American Academy of Dermatology, 1988
- Isotretinoin-induced thrombocytopeniaJournal of the American Academy of Dermatology, 1987
- Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoinJournal of the American Academy of Dermatology, 1987
- Acute arthritis during isotretinoin therapy for acneJournal of the American Academy of Dermatology, 1986
- Isotretinoin treatment of acne and related disorders: An updateJournal of the American Academy of Dermatology, 1983